Article Information
History
- January 28, 2021.
Article Versions
- You are currently viewing Version 1 of this article (January 28, 2021 - 01:04).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jason Neidleman1,2,†,
- Xiaoyu Luo1,†,
- Ashley F. George1,2,†,
- Matthew McGregor1,2,†,
- Junkai Yang3,
- Cassandra Yun4,
- Victoria Murray5,
- Gurjot Gill5,
- Warner C. Greene1,6,
- Joshua Vasquez6,
- Sulggi Lee5,
- Eliver Ghosn3,7,*,
- Kara Lynch4,* and
- Nadia R. Roan1,2,*,#
- 1Gladstone Institutes, San Francisco, CA, USA
- 2Department of Urology, University of California, San Francisco, CA, USA
- 3Department of Medicine, Lowance Center for Human Immunology, Emory Vaccine Center, Emory University, Atlanta, GA, USA
- 4Department of Laboratory Medicine, University of California, San Francisco, CA USA
- 5Zuckerberg San Francisco General Hospital and the University of California, San Francisco, CA, USA
- 6Department of Medicine, University of California, San Francisco, CA, USA
- 7Department of Pediatrics, Lowance Center for Human Immunology, Emory Vaccine Center, Emory University, Atlanta, GA, USA
- ↵*Co-correspondence: nadia.roan{at}gladstone.ucsf.edu, kara.lynch{at}ucsf.edu, eliver.ghosn{at}emory.edu
↵† Equal contribution
Posted January 28, 2021.
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19
